[Form 4] PetMed Express, Inc. Insider Trading Activity

Rhea-AI Filing Summary

PetMed Express Inc. (PETS) Form 4 filing reports that 10% owner Silvercape Investments Ltd purchased 2,817 common shares on 07 July 02 2025 at $3.22 per share, for an outlay of roughly $9.1 thousand. Following the transaction, Silvercape directly holds 2,311,230 shares of PETS. The purchase increases the investor’s stake by about 0.12%, indicating incremental but limited additional commitment to the company.

Positive

• Insider buying: A 10% owner increased their stake, which can be interpreted as confidence in PETS shares.

Negative

• Immaterial size: The 2,817-share addition represents only about 0.12% of the holder’s overall position, offering limited informational value.

Insights

Financial Analyst

TL;DR: 10% owner adds 2,817 PETS shares; immaterial size, mildly positive signal, neutral overall impact.

The filing shows a small open-market purchase by a long-term 10% holder. While insider buying can signal confidence, the ~$9k purchase is negligible relative to the existing 2.31 million-share position and PETS’ public float. The move does not alter control dynamics nor provide insight into operating fundamentals. Consequently, I view the disclosure as neutral for valuation, with a slight positive sentiment bias due to direction (buy vs. sell).

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Silvercape Investments Ltd

(Last) (First) (Middle)

FOURTH FLOOR, ONE CAPITAL PLACE

P.O. BOX 847

(Street)

GRAND CAYMAN E9 KY1-1103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PETMED EXPRESS INC [ PETS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.001	07/02/2025		P		2,817	A	$3.22	2,311,230	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Peter Kennedy	07/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who bought additional PetMed Express (PETS) shares?

Silvercape Investments Ltd, a 10% owner, purchased the shares.

How many PETS shares were acquired in this Form 4?

The filing reports a purchase of 2,817 common shares.

What was the purchase price per share?

The shares were bought at $3.22 each.

What is Silvercape Investments' total PETS ownership after the trade?

They now directly hold 2,311,230 shares.

Does this filing indicate a buy or sell transaction?

It indicates a purchase (code P) transaction.

Is the transaction large enough to affect PETS’ ownership structure?

No, the acquisition is relatively small compared with the holder’s existing stake.